Vaccination: AstraZeneca put under pressure by the European Commission


Critics focus mainly on the delays in delivery of vaccine doses ordered by the European Union.

This is a strong warning from the European Commission to AstraZeneca. On Friday, the group said it would deliver just 40% of the 31 million vaccine doses promised to Europe in the first quarter due to a “Drop in yield”on a production site. In return, the President of the European Commission Ursula von der Leyen, indicated Monday morning to the CEO of AstraZeneca, Pascal Soriot, that she wanted this company “Honor the contracts and conditions provided for in the pre-order agreement”.The warning applies to all the other pharmaceutical giants with which Brussels has signed a contract. There are seven in total.

In fact, these contracts provide for financial aid to allow manufacturers to increase their production capacities and keep up. As such, AstraZeneca would have received some 336 million euros, according to Reuters. The Vaccines Steering Committee, which brings together representatives of the Member States

This article is for subscribers only. You have 69% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

Already subscribed? Log in

.

Leave a Reply

Your email address will not be published. Required fields are marked *